Mr. Chen and his Shanda Group company affiliates sold more than 4.5 million shares of CHS from March 4-10 for between $8.70 and $9.83, bringing in a total of $41.95 million. The move comes after he sold more than 16 million shares of CHS between Nov. 10 and Jan. 15.
Mr. Chen, a pioneer in China’s online gaming industry, began buying up shares of CHS in 2016. The last public comment the investor made about CHS was in 2018, when Shanda Group said it had a “good relationship” with CHS and supported the company’s strategy and management team.
CHS, which operates 85 hospitals in 16 states, ended the fourth quarter of last year with net income of $311 million on revenue of $3.1 billion, compared to a net loss of $373 million on revenues of $3.3 billion in the same period a year earlier.
More articles on healthcare finance:
Major health systems report $1B+ annual profits
4 recent health system credit rating downgrades
6 hospitals laying off workers
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
